organization · Reporting owner
Bay Shore Trust
Disclosed activity across 2 companies
Sign in to followReported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| MIRA PHARMACEUTICALS, INC.MIRA · Entity 7362 | 10% owner | August 28, 2024 | August 30, 2024 |
| Telomir Pharmaceuticals, Inc.TELO · Entity 6962 | 10% owner | November 21, 2024 | November 25, 2024 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
MIRA PHARMACEUTICALS, INC.
Report date August 28, 2024 · Filed August 30, 2024
Jointly reported with McNulty Brian Patrick
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | IndirectBy Trust | 2,540,270 |
Reported balance
After 2024-08-28 transaction · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · 2024-08-28 · Sale · Disposed 200,000 · Balance 2,540,270 F1: As trustee of the Bay Shore Trust and the Celeste J Williams Lifetime QTIP Trust, Mr. McNulty has sole voting and dispositive power over the shares held by each trust, and, as a result is deemed to have beneficial ownership (as determined under Section 13(d) of the Exchange Act) of the securities held by the trusts. The address for the Bay Shore Trust is 900 West Platt Street, Suite 200, Tampa, Florida, 33606. |
| Common StockSEC Table I · non-derivative | IndirectBy Trust | 660,000 |
Reported balance
Holding disclosure · report date 2024-08-28 · row 3
Holding and transaction disclosures are not merged.
1 source rowRow 3 · Balance 660,000 F1: As trustee of the Bay Shore Trust and the Celeste J Williams Lifetime QTIP Trust, Mr. McNulty has sole voting and dispositive power over the shares held by each trust, and, as a result is deemed to have beneficial ownership (as determined under Section 13(d) of the Exchange Act) of the securities held by the trusts. The address for the Bay Shore Trust is 900 West Platt Street, Suite 200, Tampa, Florida, 33606. |
| Common StockSEC Table I · non-derivative | Direct | 10,000 |
Reported balance
Holding disclosure · report date 2024-08-28 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 10,000 F2: These securities are owned directly by Mr. McNulty |
Filing footnotes · ownership attribution and instrument terms
F1: As trustee of the Bay Shore Trust and the Celeste J Williams Lifetime QTIP Trust, Mr. McNulty has sole voting and dispositive power over the shares held by each trust, and, as a result is deemed to have beneficial ownership (as determined under Section 13(d) of the Exchange Act) of the securities held by the trusts. The address for the Bay Shore Trust is 900 West Platt Street, Suite 200, Tampa, Florida, 33606.
F2: These securities are owned directly by Mr. McNulty
Telomir Pharmaceuticals, Inc.
Report date November 21, 2024 · Filed November 25, 2024
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Stock (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $3.73 · Expires 2028-06-15 | IndirectBy Trust | 2,339,025 |
Reported balance
After 2024-11-21 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2024-11-21 · Gift · Disposed 100,000 · Balance 2,339,025 F2: Bona Fide Gift. No compensation was given to the donor for the gifting of securities. F1: These securities are owned directly by the Bay Shore Trust (the "Trust"), a 10% owner of the Issuer, and indirectly by Brian McNulty ("Mr. McNulty") as trustee of the Trust. Mr. McNulty disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein. |
Filing footnotes · ownership attribution and instrument terms
F1: These securities are owned directly by the Bay Shore Trust (the "Trust"), a 10% owner of the Issuer, and indirectly by Brian McNulty ("Mr. McNulty") as trustee of the Trust. Mr. McNulty disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.
F2: Bona Fide Gift. No compensation was given to the donor for the gifting of securities.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| November 21, 2024 Filed Nov 25, 2024 22:06 UTC | Telomir Pharmaceuticals, Inc. TELO · Entity 6962 | GiftCommon Stock (right to buy) · Derivative | 100,000 | Not disclosed Strike: $3.73 | Not disclosed |
DisclosureSEC source: 0001493152-24-047638 · ownership.xml · derivative · entry 1 Bay Shore Trust · CIK 0001986593 · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · By Trust Disclosed balance after: 2,339,025 Underlying: Common Stock · 100,000 shares Expires 2028-06-15 F2 · price: Bona Fide Gift. No compensation was given to the donor for the gifting of securities. F1 · ownership.nature: These securities are owned directly by the Bay Shore Trust (the "Trust"), a 10% owner of the Issuer, and indirectly by Brian McNulty ("Mr. McNulty") as trustee of the Trust. Mr. McNulty disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein. Read SEC document |
| August 28, 2024 Filed Aug 30, 2024 20:05 UTC | MIRA PHARMACEUTICALS, INC. MIRA · Entity 7362 | SaleCommon Stock | 200,000 | $1.96 | $392,000.00 |
DisclosureSEC source: 0001493152-24-034584 · ownership.xml · nonDerivative · entry 1 McNulty Brian Patrick · CIK 0001996353 · 10% owner Bay Shore Trust · CIK 0001986593 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · By Trust Disclosed balance after: 2,540,270 F1 · ownership.nature: As trustee of the Bay Shore Trust and the Celeste J Williams Lifetime QTIP Trust, Mr. McNulty has sole voting and dispositive power over the shares held by each trust, and, as a result is deemed to have beneficial ownership (as determined under Section 13(d) of the Exchange Act) of the securities held by the trusts. The address for the Bay Shore Trust is 900 West Platt Street, Suite 200, Tampa, Florida, 33606. Read SEC document |
| February 13, 2024 Filed Feb 15, 2024 21:11 UTC | Telomir Pharmaceuticals, Inc. TELO · Entity 6962 | PurchaseCommon Stock | 49,000 | $7.00 | $343,000.00 |
DisclosureSEC source: 0000897069-24-000395 · form4.xml · nonDerivative · entry 3 Bay Shore Trust · CIK 0001986593 · 10% owner McNulty Brian Patrick · CIK 0001996353 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · By Trust Disclosed balance after: 1,902,659 F3 · ownership.nature: These securities are owned directly by a trust for which Mr. McNulty serves as trustee. Mr. McNulty disclaims beneficial ownership of the reported securities because he is deemed to hold these securities only because of his role as Trustee and does not have any pecuniary interest in such securities. Read SEC document |
| February 13, 2024 Filed Feb 15, 2024 21:11 UTC | Telomir Pharmaceuticals, Inc. TELO · Entity 6962 | PurchaseCommon Stock | 40,000 | $7.00 | $280,000.00 |
DisclosureSEC source: 0000897069-24-000395 · form4.xml · nonDerivative · entry 2 Bay Shore Trust · CIK 0001986593 · 10% owner McNulty Brian Patrick · CIK 0001996353 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnote Disclosed balance after: 1,365,646 F2 · ownership.nature: These securities are owned directly by the MIRALOGX, LLC, of which the Trust holds all of the membership interests, and indirectly by Mr. McNulty as trustee of the Trust. Mr. McNulty disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein. Read SEC document |
| February 13, 2024 Filed Feb 15, 2024 21:11 UTC | Telomir Pharmaceuticals, Inc. TELO · Entity 6962 | PurchaseCommon Stock | 49,000 | $7.00 | $343,000.00 |
DisclosureSEC source: 0000897069-24-000395 · form4.xml · nonDerivative · entry 1 Bay Shore Trust · CIK 0001986593 · 10% owner McNulty Brian Patrick · CIK 0001996353 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · By Trust Disclosed balance after: 5,455,431 F1 · ownership.nature: These securities are owned directly by the Bay Shore Trust (the "Trust"), a 10% owner of the Issuer, and indirectly by Brian McNulty ("Mr. McNulty") as trustee of the Trust. Mr. McNulty disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein. Read SEC document |
| December 11, 2023 Filed Dec 27, 2023 22:33 UTC | MIRA PHARMACEUTICALS, INC. MIRA · Entity 7362 | SaleCommon Stock | 23,002 | $1.55 | $35,747.41 |
DisclosureSEC source: 0000897069-23-001850 · form4.xml · nonDerivative · entry 22 McNulty Brian Patrick · CIK 0001996353 · 10% owner Bay Shore Trust · CIK 0001986593 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · By Trust Disclosed balance after: 660,000 F2 · ownership.nature: These securities are owned directly by a trust for which Mr. McNulty serves as trustee. Mr. McNulty disclaims beneficial ownership of the reported securities because he is deemed to hold these securities only because of his role as Trustee and does not have any pecuniary interest in such securities. Read SEC document |
| December 11, 2023 Filed Dec 27, 2023 22:33 UTC | MIRA PHARMACEUTICALS, INC. MIRA · Entity 7362 | SaleCommon Stock | 23,003 | $1.55 | $35,748.96 |
DisclosureSEC source: 0000897069-23-001850 · form4.xml · nonDerivative · entry 11 McNulty Brian Patrick · CIK 0001996353 · 10% owner Bay Shore Trust · CIK 0001986593 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · By Trust Disclosed balance after: 2,740,270 F1 · ownership.nature: These securities are owned directly by the Bay Shore Trust (the "Trust"), a 10% owner of the Issuer, and indirectly by Mr. McNulty as trustee of the Trust. Mr. McNulty disclaims beneficial ownership of the reported securities because he is deemed to hold these securities only because of his role as Trustee and does not have any pecuniary interest in such securities. Read SEC document |
| December 08, 2023 Filed Dec 27, 2023 22:33 UTC | MIRA PHARMACEUTICALS, INC. MIRA · Entity 7362 | SaleCommon Stock | 9,527 | $1.61 | $15,317.51 |
DisclosureSEC source: 0000897069-23-001850 · form4.xml · nonDerivative · entry 21 McNulty Brian Patrick · CIK 0001996353 · 10% owner Bay Shore Trust · CIK 0001986593 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · By Trust Disclosed balance after: 683,002 F2 · ownership.nature: These securities are owned directly by a trust for which Mr. McNulty serves as trustee. Mr. McNulty disclaims beneficial ownership of the reported securities because he is deemed to hold these securities only because of his role as Trustee and does not have any pecuniary interest in such securities. Read SEC document |
| December 08, 2023 Filed Dec 27, 2023 22:33 UTC | MIRA PHARMACEUTICALS, INC. MIRA · Entity 7362 | SaleCommon Stock | 9,526 | $1.61 | $15,315.90 |
DisclosureSEC source: 0000897069-23-001850 · form4.xml · nonDerivative · entry 10 McNulty Brian Patrick · CIK 0001996353 · 10% owner Bay Shore Trust · CIK 0001986593 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · By Trust Disclosed balance after: 2,763,273 F1 · ownership.nature: These securities are owned directly by the Bay Shore Trust (the "Trust"), a 10% owner of the Issuer, and indirectly by Mr. McNulty as trustee of the Trust. Mr. McNulty disclaims beneficial ownership of the reported securities because he is deemed to hold these securities only because of his role as Trustee and does not have any pecuniary interest in such securities. Read SEC document |
| December 07, 2023 Filed Dec 27, 2023 22:33 UTC | MIRA PHARMACEUTICALS, INC. MIRA · Entity 7362 | SaleCommon Stock | 16,667 | $1.89 | $31,578.96 |
DisclosureSEC source: 0000897069-23-001850 · form4.xml · nonDerivative · entry 20 McNulty Brian Patrick · CIK 0001996353 · 10% owner Bay Shore Trust · CIK 0001986593 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · By Trust Disclosed balance after: 692,529 F2 · ownership.nature: These securities are owned directly by a trust for which Mr. McNulty serves as trustee. Mr. McNulty disclaims beneficial ownership of the reported securities because he is deemed to hold these securities only because of his role as Trustee and does not have any pecuniary interest in such securities. Read SEC document |
| December 07, 2023 Filed Dec 27, 2023 22:33 UTC | MIRA PHARMACEUTICALS, INC. MIRA · Entity 7362 | SaleCommon Stock | 16,666 | $1.89 | $31,577.07 |
DisclosureSEC source: 0000897069-23-001850 · form4.xml · nonDerivative · entry 9 McNulty Brian Patrick · CIK 0001996353 · 10% owner Bay Shore Trust · CIK 0001986593 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · By Trust Disclosed balance after: 2,772,799 F1 · ownership.nature: These securities are owned directly by the Bay Shore Trust (the "Trust"), a 10% owner of the Issuer, and indirectly by Mr. McNulty as trustee of the Trust. Mr. McNulty disclaims beneficial ownership of the reported securities because he is deemed to hold these securities only because of his role as Trustee and does not have any pecuniary interest in such securities. Read SEC document |
| December 06, 2023 Filed Dec 27, 2023 22:33 UTC | MIRA PHARMACEUTICALS, INC. MIRA · Entity 7362 | SaleCommon Stock | 13,866 | $2.95 | $40,890.83 |
DisclosureSEC source: 0000897069-23-001850 · form4.xml · nonDerivative · entry 19 McNulty Brian Patrick · CIK 0001996353 · 10% owner Bay Shore Trust · CIK 0001986593 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · By Trust Disclosed balance after: 709,196 F2 · ownership.nature: These securities are owned directly by a trust for which Mr. McNulty serves as trustee. Mr. McNulty disclaims beneficial ownership of the reported securities because he is deemed to hold these securities only because of his role as Trustee and does not have any pecuniary interest in such securities. Read SEC document |
| December 06, 2023 Filed Dec 27, 2023 22:33 UTC | MIRA PHARMACEUTICALS, INC. MIRA · Entity 7362 | SaleCommon Stock | 13,867 | $2.95 | $40,893.78 |
DisclosureSEC source: 0000897069-23-001850 · form4.xml · nonDerivative · entry 8 McNulty Brian Patrick · CIK 0001996353 · 10% owner Bay Shore Trust · CIK 0001986593 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · By Trust Disclosed balance after: 2,789,465 F1 · ownership.nature: These securities are owned directly by the Bay Shore Trust (the "Trust"), a 10% owner of the Issuer, and indirectly by Mr. McNulty as trustee of the Trust. Mr. McNulty disclaims beneficial ownership of the reported securities because he is deemed to hold these securities only because of his role as Trustee and does not have any pecuniary interest in such securities. Read SEC document |
| December 04, 2023 Filed Dec 27, 2023 22:33 UTC | MIRA PHARMACEUTICALS, INC. MIRA · Entity 7362 | SaleCommon Stock | 30,666 | $3.98 | $122,050.68 |
DisclosureSEC source: 0000897069-23-001850 · form4.xml · nonDerivative · entry 18 McNulty Brian Patrick · CIK 0001996353 · 10% owner Bay Shore Trust · CIK 0001986593 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · By Trust Disclosed balance after: 723,062 F2 · ownership.nature: These securities are owned directly by a trust for which Mr. McNulty serves as trustee. Mr. McNulty disclaims beneficial ownership of the reported securities because he is deemed to hold these securities only because of his role as Trustee and does not have any pecuniary interest in such securities. Read SEC document |
| December 04, 2023 Filed Dec 27, 2023 22:33 UTC | MIRA PHARMACEUTICALS, INC. MIRA · Entity 7362 | SaleCommon Stock | 30,665 | $3.98 | $122,046.70 |
DisclosureSEC source: 0000897069-23-001850 · form4.xml · nonDerivative · entry 7 McNulty Brian Patrick · CIK 0001996353 · 10% owner Bay Shore Trust · CIK 0001986593 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · By Trust Disclosed balance after: 2,803,332 F1 · ownership.nature: These securities are owned directly by the Bay Shore Trust (the "Trust"), a 10% owner of the Issuer, and indirectly by Mr. McNulty as trustee of the Trust. Mr. McNulty disclaims beneficial ownership of the reported securities because he is deemed to hold these securities only because of his role as Trustee and does not have any pecuniary interest in such securities. Read SEC document |
| November 30, 2023 Filed Dec 27, 2023 22:33 UTC | MIRA PHARMACEUTICALS, INC. MIRA · Entity 7362 | SaleCommon Stock | 2,421 | $3.77 | $9,136.37 |
DisclosureSEC source: 0000897069-23-001850 · form4.xml · nonDerivative · entry 17 McNulty Brian Patrick · CIK 0001996353 · 10% owner Bay Shore Trust · CIK 0001986593 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · By Trust Disclosed balance after: 753,728 F2 · ownership.nature: These securities are owned directly by a trust for which Mr. McNulty serves as trustee. Mr. McNulty disclaims beneficial ownership of the reported securities because he is deemed to hold these securities only because of his role as Trustee and does not have any pecuniary interest in such securities. Read SEC document |
| November 30, 2023 Filed Dec 27, 2023 22:33 UTC | MIRA PHARMACEUTICALS, INC. MIRA · Entity 7362 | SaleCommon Stock | 2,421 | $3.77 | $9,136.37 |
DisclosureSEC source: 0000897069-23-001850 · form4.xml · nonDerivative · entry 6 McNulty Brian Patrick · CIK 0001996353 · 10% owner Bay Shore Trust · CIK 0001986593 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · By Trust Disclosed balance after: 2,833,997 F1 · ownership.nature: These securities are owned directly by the Bay Shore Trust (the "Trust"), a 10% owner of the Issuer, and indirectly by Mr. McNulty as trustee of the Trust. Mr. McNulty disclaims beneficial ownership of the reported securities because he is deemed to hold these securities only because of his role as Trustee and does not have any pecuniary interest in such securities. Read SEC document |
| November 29, 2023 Filed Dec 27, 2023 22:33 UTC | MIRA PHARMACEUTICALS, INC. MIRA · Entity 7362 | SaleCommon Stock | 3,700 | $3.98 | $14,724.52 |
DisclosureSEC source: 0000897069-23-001850 · form4.xml · nonDerivative · entry 16 McNulty Brian Patrick · CIK 0001996353 · 10% owner Bay Shore Trust · CIK 0001986593 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · By Trust Disclosed balance after: 756,149 F2 · ownership.nature: These securities are owned directly by a trust for which Mr. McNulty serves as trustee. Mr. McNulty disclaims beneficial ownership of the reported securities because he is deemed to hold these securities only because of his role as Trustee and does not have any pecuniary interest in such securities. Read SEC document |
| November 29, 2023 Filed Dec 27, 2023 22:33 UTC | MIRA PHARMACEUTICALS, INC. MIRA · Entity 7362 | SaleCommon Stock | 3,699 | $3.98 | $14,720.54 |
DisclosureSEC source: 0000897069-23-001850 · form4.xml · nonDerivative · entry 5 McNulty Brian Patrick · CIK 0001996353 · 10% owner Bay Shore Trust · CIK 0001986593 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · By Trust Disclosed balance after: 2,836,418 F1 · ownership.nature: These securities are owned directly by the Bay Shore Trust (the "Trust"), a 10% owner of the Issuer, and indirectly by Mr. McNulty as trustee of the Trust. Mr. McNulty disclaims beneficial ownership of the reported securities because he is deemed to hold these securities only because of his role as Trustee and does not have any pecuniary interest in such securities. Read SEC document |
| November 28, 2023 Filed Dec 27, 2023 22:33 UTC | MIRA PHARMACEUTICALS, INC. MIRA · Entity 7362 | SaleCommon Stock | 120 | $4.00 | $480.00 |
DisclosureSEC source: 0000897069-23-001850 · form4.xml · nonDerivative · entry 15 McNulty Brian Patrick · CIK 0001996353 · 10% owner Bay Shore Trust · CIK 0001986593 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · By Trust Disclosed balance after: 759,849 F2 · ownership.nature: These securities are owned directly by a trust for which Mr. McNulty serves as trustee. Mr. McNulty disclaims beneficial ownership of the reported securities because he is deemed to hold these securities only because of his role as Trustee and does not have any pecuniary interest in such securities. Read SEC document |
| November 28, 2023 Filed Dec 27, 2023 22:33 UTC | MIRA PHARMACEUTICALS, INC. MIRA · Entity 7362 | SaleCommon Stock | 121 | $4.00 | $484.00 |
DisclosureSEC source: 0000897069-23-001850 · form4.xml · nonDerivative · entry 4 McNulty Brian Patrick · CIK 0001996353 · 10% owner Bay Shore Trust · CIK 0001986593 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · By Trust Disclosed balance after: 2,840,117 F1 · ownership.nature: These securities are owned directly by the Bay Shore Trust (the "Trust"), a 10% owner of the Issuer, and indirectly by Mr. McNulty as trustee of the Trust. Mr. McNulty disclaims beneficial ownership of the reported securities because he is deemed to hold these securities only because of his role as Trustee and does not have any pecuniary interest in such securities. Read SEC document |
| November 27, 2023 Filed Dec 27, 2023 22:33 UTC | MIRA PHARMACEUTICALS, INC. MIRA · Entity 7362 | SaleCommon Stock | 3,212 | $4.00 | $12,855.71 |
DisclosureSEC source: 0000897069-23-001850 · form4.xml · nonDerivative · entry 14 McNulty Brian Patrick · CIK 0001996353 · 10% owner Bay Shore Trust · CIK 0001986593 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · By Trust Disclosed balance after: 759,969 F2 · ownership.nature: These securities are owned directly by a trust for which Mr. McNulty serves as trustee. Mr. McNulty disclaims beneficial ownership of the reported securities because he is deemed to hold these securities only because of his role as Trustee and does not have any pecuniary interest in such securities. Read SEC document |
| November 27, 2023 Filed Dec 27, 2023 22:33 UTC | MIRA PHARMACEUTICALS, INC. MIRA · Entity 7362 | SaleCommon Stock | 3,213 | $4.00 | $12,859.71 |
DisclosureSEC source: 0000897069-23-001850 · form4.xml · nonDerivative · entry 3 McNulty Brian Patrick · CIK 0001996353 · 10% owner Bay Shore Trust · CIK 0001986593 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · By Trust Disclosed balance after: 2,840,238 F1 · ownership.nature: These securities are owned directly by the Bay Shore Trust (the "Trust"), a 10% owner of the Issuer, and indirectly by Mr. McNulty as trustee of the Trust. Mr. McNulty disclaims beneficial ownership of the reported securities because he is deemed to hold these securities only because of his role as Trustee and does not have any pecuniary interest in such securities. Read SEC document |
| November 21, 2023 Filed Dec 27, 2023 22:33 UTC | MIRA PHARMACEUTICALS, INC. MIRA · Entity 7362 | SaleCommon Stock | 2,500 | $5.00 | $12,500.00 |
DisclosureSEC source: 0000897069-23-001850 · form4.xml · nonDerivative · entry 13 McNulty Brian Patrick · CIK 0001996353 · 10% owner Bay Shore Trust · CIK 0001986593 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · By Trust Disclosed balance after: 763,181 F2 · ownership.nature: These securities are owned directly by a trust for which Mr. McNulty serves as trustee. Mr. McNulty disclaims beneficial ownership of the reported securities because he is deemed to hold these securities only because of his role as Trustee and does not have any pecuniary interest in such securities. Read SEC document |
| November 21, 2023 Filed Dec 27, 2023 22:33 UTC | MIRA PHARMACEUTICALS, INC. MIRA · Entity 7362 | SaleCommon Stock | 2,500 | $5.00 | $12,500.00 |
DisclosureSEC source: 0000897069-23-001850 · form4.xml · nonDerivative · entry 2 McNulty Brian Patrick · CIK 0001996353 · 10% owner Bay Shore Trust · CIK 0001986593 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · By Trust Disclosed balance after: 2,843,451 F1 · ownership.nature: These securities are owned directly by the Bay Shore Trust (the "Trust"), a 10% owner of the Issuer, and indirectly by Mr. McNulty as trustee of the Trust. Mr. McNulty disclaims beneficial ownership of the reported securities because he is deemed to hold these securities only because of his role as Trustee and does not have any pecuniary interest in such securities. Read SEC document |
| November 20, 2023 Filed Dec 27, 2023 22:33 UTC | MIRA PHARMACEUTICALS, INC. MIRA · Entity 7362 | SaleCommon Stock | 13,366 | $5.07 | $67,758.94 |
DisclosureSEC source: 0000897069-23-001850 · form4.xml · nonDerivative · entry 12 McNulty Brian Patrick · CIK 0001996353 · 10% owner Bay Shore Trust · CIK 0001986593 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · By Trust Disclosed balance after: 765,681 F2 · ownership.nature: These securities are owned directly by a trust for which Mr. McNulty serves as trustee. Mr. McNulty disclaims beneficial ownership of the reported securities because he is deemed to hold these securities only because of his role as Trustee and does not have any pecuniary interest in such securities. Read SEC document |
| November 20, 2023 Filed Dec 27, 2023 22:33 UTC | MIRA PHARMACEUTICALS, INC. MIRA · Entity 7362 | SaleCommon Stock | 13,367 | $5.07 | $67,764.01 |
DisclosureSEC source: 0000897069-23-001850 · form4.xml · nonDerivative · entry 1 McNulty Brian Patrick · CIK 0001996353 · 10% owner Bay Shore Trust · CIK 0001986593 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · By Trust Disclosed balance after: 2,845,951 F1 · ownership.nature: These securities are owned directly by the Bay Shore Trust (the "Trust"), a 10% owner of the Issuer, and indirectly by Mr. McNulty as trustee of the Trust. Mr. McNulty disclaims beneficial ownership of the reported securities because he is deemed to hold these securities only because of his role as Trustee and does not have any pecuniary interest in such securities. Read SEC document |
| November 15, 2023 Filed Nov 17, 2023 22:09 UTC | MIRA PHARMACEUTICALS, INC. MIRA · Entity 7362 | GrantCommon Stock Warrant (right to buy) · Derivative | 700,000 | Not disclosed Strike: $2.00 | Not disclosed |
DisclosureSEC source: 0000897069-23-001617 · form4.xml · derivative · entry 1 Bay Shore Trust · CIK 0001986593 · 10% owner McNulty Brian Patrick · CIK 0001996353 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnote Disclosed balance after: 700,000 Underlying: Common Stock · 700,000 shares Expires 2028-11-15 F1 · price: The warrants were issued to MIRALOGX LLC ("MIRALOGX"), a wholly-owned subsidiary of the Bay Shore Trust (the "Trust"), a greater than 10% owner of the Issuer, in connection with an Exclusive License Agreement, dated November 15, 2023, by and between MIRALOGX and the Issuer. The Trust may be deemed to beneficially own the shares held by MIRALOGX but disclaims beneficial ownership except to the extent of its pecuniary interest therein, if any. F1 · ownership.nature: The warrants were issued to MIRALOGX LLC ("MIRALOGX"), a wholly-owned subsidiary of the Bay Shore Trust (the "Trust"), a greater than 10% owner of the Issuer, in connection with an Exclusive License Agreement, dated November 15, 2023, by and between MIRALOGX and the Issuer. The Trust may be deemed to beneficially own the shares held by MIRALOGX but disclaims beneficial ownership except to the extent of its pecuniary interest therein, if any. Read SEC document |
| August 07, 2023 Filed Aug 24, 2023 21:38 UTC | MIRA PHARMACEUTICALS, INC. MIRA · Entity 7362 | PurchaseCommon Stock | 119,048 | $7.00 | $833,336.00 |
DisclosureSEC source: 0000897069-23-001265 · form4.xml · nonDerivative · entry 1 Cappy George · CIK 0001986372 · 10% owner Bay Shore Trust · CIK 0001986593 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · By Trust Disclosed balance after: 2,859,318 F1 · ownership.nature: These securities are owned directly by the Bay Shore Trust (the "Trust"), a greater-than-10% owner of the Issuer. As sole trustee of the Trust, George Cappy ("Mr. Cappy") has sole ownership and dispositive power over these securities and is therefore deemed to be an indirect beneficial owner of the securities for purposes of SEC Rule 13d-3, although Mr. Cappy disclaims beneficial ownership of the reported securities due to the absence of any pecuniary interest therein. Read SEC document |
| August 02, 2023 Filed Aug 4, 2023 17:42 UTC | MIRA PHARMACEUTICALS, INC. MIRA · Entity 7362 | PurchaseCommon Stock | 157,170 | $7.00 | $1,100,190.00 |
DisclosureSEC source: 0000897069-23-001091 · form4.xml · nonDerivative · entry 1 Cappy George · CIK 0001986372 · 10% owner Bay Shore Trust · CIK 0001986593 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · By Trust Disclosed balance after: 2,740,270 F1 · kind: Represents the acquisition of shares of common stock by the Bay Shore Trust (the "Trust") through the conversion of an aggregate of $1,100,190 of indebtedness owing by the Issuer to the Trust, with such conversion occurring on the date of the Issuer's initial public offering at a conversion price of $7.00 per share. F2 · ownership.nature: These securities are owned directly by the Trust, a greater-than-10% owner of the Issuer. As sole trustee of the Trust, George Cappy ("Mr. Cappy") has sole ownership and dispositive power over these securities and is therefore deemed to be an indirect beneficial owner of the securities for purposes of SEC Rule 13d-3, although Mr. Cappy disclaims beneficial ownership of the reported securities due to the absence of any pecuniary interest therein. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.